PRELUDE THERAPEUTICS INC Gain (Loss) on Disposition of Property Plant Equipment
PRELUDE THERAPEUTICS INC (PRLD) reported Gain (Loss) on Disposition of Property Plant Equipment of -$11.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-17.
Discontinued › Income Statement
us-gaap:GainLossOnSaleOfPropertyPlantEquipment · last filed 2022-03-17
- PRELUDE THERAPEUTICS INC gain (loss) on disposition of property plant equipment for fiscal 2020 was -$11.00K.
- PRELUDE THERAPEUTICS INC gain (loss) on disposition of property plant equipment for fiscal 2019 was -$10.00K.
| Period end | Gain (Loss) on Disposition of Property Plant Equipment 12 month |
|---|---|
| 2020-12-31 | -$11.00K 10-K · filed 2022-03-17 |
| 2019-12-31 | -$10.00K 10-K · filed 2021-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |